CLINICAL_TRIALS
trial_result
· 2026-03-16
Clinical Trial Update: INDV-6001 Multiple-Dose Pharmacokinetic Study [Phase 2]
Summary
The Phase 2 multiple-dose pharmacokinetic study of INDV-6001 in adults with moderate to severe opioid use disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indivior Inc. | Conditions: Moderate to Severe Opioid Use Disorder | Phase 2 | Status: COMPLETED